For more information or confidential assistance
Call 800-306-3180

Staff Writer

Research Reveals the High Risks of Pradaxa

New research into the popular blood thinners dabigatran (brand name Pradaxa) and warfarin (brand name Coumadin) indicate that the risks associated with dabigatran – Pradaxa internal bleeding, hemorrhaging, and even death from Pradaxa – are greater than those linked to warfarin. This information will likely... Read More

New Mexico Woman Joins Yaz MDL

A New Mexico resident, Stephanie Brazil, has filed a lawsuit in the United States District Court for the Southern District of Illinois against drug maker Bayer Pharmaceuticals, the company responsible for the manufacture and marketing of the popular fourth generation drospirenone-based birth control known as... Read More

Federal Court Considers Motion for Pradaxa MDL

In response to the ballooning number of plaintiffs choosing to file a Pradaxa lawsuit, a motion has been filed with the U.S. Judicial Panel on Multidistrict Litigation seeking to consolidate lawsuits against Pradaxa manufacturer Boehringer Ingelheim that share common issues of fact. The motion seeks... Read More

Actos MDL Grows in Louisiana

The current multi district litigation case dealing with the type II diabetes drug Actos has recently grown by one lawsuit dealing with the case of an Indiana man who allegedly developed bladder cancer after taking the medication. Ralph Penrod of Hartford City filed his lawsuit... Read More